Literature DB >> 6284989

Cloning of two genetically transmitted Moloney leukemia proviral genomes: correlation between biological activity of the cloned DNA and viral genome activation in the animal.

I Chumakov, H Stuhlmann, K Harbers, R Jaenisch.   

Abstract

The Mov-7 and Mov-9 substrains of mice, carrying Moloney murine leukemia virus (M-MuLV) in their germ line at the Mov-7 locus and Mov-9 locus, respectively, are different with respect to virus activation. Infectious virus appears in all mice carrying the Mov-9 locus but is not activated in animals carrying the Mov-7 locus. Consequently, only Mov-9 mice develop viremia and subsequent leukemia. The endogenous M-MuLV provirus with flanking mouse sequences corresponding to the Mov-7 and Mov-9 loci was molecularly cloned. Detailed restriction maps obtained from the cloned DNAs revealed no detectable differences in the proviral genomes. The flanking mouse sequences, however, were different, confirming that the Mov-7 and Mov-9 loci represent different integration sites of M-MuLV. Both clones induced XC plaques in a transfection assay. The specific infectivity of the clones, however, was different. A total of 10(-5) XC plaques per genome equivalent were induced by the Mov-9 clone, whereas only 10(-9) XC plaques per genome equivalent were induced by the Mov-7 clone. Moreover, NIH 3T3 cells transfected with the Mov-9 clone produced NB-tropic M-MuLV, whereas cells transfected with the Mov-7 clone did not produce infectious virus. The results suggest that M-MuLV integrated at the Mov-7 locus carries a mutation which prevents synthesis of infectious virus but permits XC plaque induction by partial genome expression or synthesis of noninfectious particles. Thus, the pattern of virus expression in Mov-7 and Mov-9 mice correlates with the biological properties of the respective clones. Genomic DNA from Mov-9 mice was not infectious in the transfection assay (specific infectivity < 10(-7) PFU per genome equivalent). As the only difference between the genomic and the cloned Mov-9 DNA appears to be the presence of 5-methylcytosine in CpG sequences, our results suggest that removal of methyl groups by molecular cloning in procaryotes permits genome expression in transfected eucaryotic cells. Our results support the hypothesis that DNA methylation is relevant not only in genome expression in the animal but also in expression of genes transfected into eucaryotic cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6284989      PMCID: PMC256946     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Packaging recombinant DNA molecules into bacteriophage particles in vitro.

Authors:  B Hohn; K Murray
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

3.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

4.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

5.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

6.  Germ line integration of moloney leukemia virus: effect of homozygosity at the m-mulV locus.

Authors:  R Jaenisch
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

7.  Germ line integration and Mendelian transmission of the exogenous Moloney leukemia virus.

Authors:  R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

8.  Infection of preimplantation mouse embryos and of newborn mice with leukemia virus: tissue distribution of viral DNA and RNA and leukemogenesis in the adult animal.

Authors:  R Jaenisch; H Fan; B Croker
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

9.  A replication-defective variant of Moloney murine leukemia virus. I. Biological characterization.

Authors:  A L Rein; B I Gerwin; R H Bassin; L Schwarm; G Schidlovsky
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

10.  Nucleotide sequence of the rightward operator of phage lambda.

Authors:  T Maniatis; A Jeffrey; D G Kleid
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

View more
  30 in total

1.  Homologous recombination of copackaged retrovirus RNAs during reverse transcription.

Authors:  H Stuhlmann; P Berg
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  A single point mutation in the envelope gene is responsible for replication and XC fusion deficiency of the endogenous ecotropic C3H/He murine leukemia virus and for its repair in culture.

Authors:  G Sithanandam; U R Rapp
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

3.  Transduction of cellular neo mRNA by retrovirus-mediated recombination.

Authors:  H Stuhlmann; M Dieckmann; P Berg
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

4.  Identification of a cis-acting element in the class I major histocompatibility complex gene promoter responsive to activation by retroviral sequences.

Authors:  S Y Choi; K van de Mark; D V Faller
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

5.  Expression of human class II major histocompatibility complex antigens using retrovirus vectors.

Authors:  A J Korman; J D Frantz; J L Strominger; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

6.  Characterization of an endogenous retrovirus-repetitive DNA chimera in the mouse genome.

Authors:  T G Fanning; D W Morris; R D Cardiff; H D Bradshaw
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

7.  Treatment of mice with 5-azacytidine efficiently activates silent retroviral genomes in different tissues.

Authors:  R Jaenisch; A Schnieke; K Harbers
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

8.  Murine retroviruses control class I major histocompatibility antigen gene expression via a trans effect at the transcriptional level.

Authors:  L D Wilson; D C Flyer; D V Faller
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

Review 9.  Clinical trials with retrovirus mediated gene therapy--what have we learned?

Authors:  Nikolai G Rainov; Huan Ren
Journal:  J Neurooncol       Date:  2003-12       Impact factor: 4.130

10.  Moloney murine leukemia virus activates NF-kappa B.

Authors:  J Pak; D V Faller
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.